Get it on Google Play

Sarepta Therapeutics (SRPT) Eteplirsen Gains Coverage at Aetna

November 21, 2016 10:21 AM EST

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) on watch as Aetna (NYSE: AET) provides coverage for eteplirsen. LINK



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA

Add Your Comment